PROVARIX

Indications

• Prevention of infectious diseases such as measles, mumps, rubella, hepatitis B, influenza, and human papillomavirus (HPV)
• Travel vaccinations for diseases endemic to certain regions
• Vaccination for at-risk populations, such as those with compromised immune systems or specific occupational exposures

Dosage

Children: Dosage varies by vaccine type and age; refer to the BNF for Children for specific dosing information.

Adults: Dosage varies by vaccine type and indication; refer to specific guidelines for each vaccine.

Mechanism of action

Vaccines work by mimicking an infection. They introduce a harmless component of a pathogen (antigen) to the immune system, prompting the body to produce an immune response. This includes the generation of antibodies and memory cells that provide long-term immunity. Upon subsequent exposure to the actual pathogen, the immune system is primed to respond more rapidly and effectively.

Pharmacodynamics

The pharmacodynamics of vaccines involves the activation of both humoral and cellular immunity. Vaccines stimulate B cells to produce antibodies against the pathogen, while T cells are activated to destroy infected cells. This dual response helps to establish immunological memory, which enables a faster and more robust response upon re-exposure to the pathogen.

Pharmacokinetics

Vaccines are administered via various routes, including intramuscular, subcutaneous, and oral. After administration, the antigens are presented to antigen-presenting cells, which activate T cells and stimulate B cell proliferation and differentiation. The half-life of vaccine-induced immunity varies depending on the type of vaccine, with some providing lifelong immunity and others requiring booster doses to maintain protection.

Contra-indications

• Severe allergic reaction (anaphylaxis) to a component of the vaccine
• Severe immunocompromised state for live attenuated vaccines

Adverse effects

• Local reactions at the injection site (pain, redness, swelling)
• Fever
• Fatigue
• Headache
• Muscle pain
• Joint pain
• Nausea

Interactions

• Immunosuppressive medications may reduce vaccine efficacy
• Concurrent administration of some vaccines may require spacing to optimize immune response

Precautions

• History of allergic reactions to vaccines or vaccine components
• Pregnancy (specific vaccines may be contraindicated)
• Moderate to severe acute illness with or without fever

Pregnancy

Consult healthcare provider. Some vaccines are contraindicated during pregnancy, while others are recommended.

Breast-feeding

Generally considered safe, but consult healthcare provider regarding specific vaccines.

Storage

Store in a refrigerator at 2-8°C. Do not freeze. Protect from light.

Formulations

• Liquid suspension for injection
• Lyophilized powder for reconstitution

Indications

• Prevention of varicella (chickenpox) in children and adults
• Post-exposure prophylaxis in individuals at high risk of severe disease

Dosage

Children: Refer to specific guidelines for varicella vaccination and management in children.

Adults: Refer to specific guidelines for varicella vaccination and management in adults.

Mechanism of action

The varicella-zoster virus enters the body through the respiratory tract and mucosal tissues. It replicates in lymphoid tissues and then disseminates through the bloodstream, leading to a systemic infection. The virus causes the characteristic skin lesions by infecting epidermal cells, leading to cell lysis and the formation of vesicular lesions. The immune response to the infection ultimately leads to the resolution of the disease and the formation of latent virus in sensory nerve ganglia.

Pharmacodynamics

The pharmacodynamics of varicella involves the immune response elicited by the body upon infection. The primary response includes the production of antibodies specific to VZV, which help to neutralize the virus and prevent further infection. Additionally, T-cell mediated immunity plays a crucial role in controlling the infection and preventing reactivation of the virus later in life, which can result in herpes zoster (shingles).

Pharmacokinetics

Varicella-zoster virus has a complex pharmacokinetic profile. After initial infection, the virus undergoes replication in lymphoid tissue, followed by viremia and subsequent infection of the skin. The onset of the rash typically occurs 10 to 21 days after exposure. The virus can remain dormant in sensory ganglia and may reactivate later in life, causing herpes zoster. The vaccine, when administered, stimulates an immune response without causing the disease, leading to the establishment of immunity.

Contra-indications

• Hypersensitivity to varicella vaccine components
• Immunocompromised individuals
• Pregnant women

Adverse effects

• Injection site reactions (pain, redness, swelling)
• Mild rash
• Fever
• Fatigue
• Headache

Interactions

• Corticosteroids may reduce vaccine effectiveness
• Immunosuppressive therapies may alter immune response to vaccination

Precautions

• Assess for history of allergic reactions to previous vaccines
• Monitor for potential interactions with immunosuppressive medications
• Consider the risk of transmission to susceptible individuals

Pregnancy

Varicella vaccine is contraindicated during pregnancy due to potential risks to the fetus.

Breast-feeding

Breastfeeding is not a contraindication for varicella vaccination; however, consult healthcare provider for individual cases.

Storage

Store at 2-8 degrees Celsius. Do not freeze. Protect from light.

Formulations

• Live attenuated varicella vaccine, administered subcutaneously